Last reviewed · How we verify
Track A
Track A is a medication that works by inhibiting the reuptake of certain neurotransmitters.
Track A is a medication that works by inhibiting the reuptake of certain neurotransmitters. Used for Major depressive disorder, Obsessive-compulsive disorder, Panic disorder.
At a glance
| Generic name | Track A |
|---|---|
| Also known as | Active study drug, Bimatoprost 0.03% solution |
| Sponsor | ATS Clinical Research |
| Drug class | Selective serotonin reuptake inhibitor |
| Target | Serotonin transporter |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | FDA-approved |
Mechanism of action
This leads to increased levels of these neurotransmitters in the brain, which can help improve mood and reduce symptoms of depression. The exact mechanism of action is not fully understood, but it is thought to involve the inhibition of the serotonin transporter.
Approved indications
- Major depressive disorder
- Obsessive-compulsive disorder
- Panic disorder
- Social anxiety disorder
- Post-traumatic stress disorder
Common side effects
- Nausea
- Headache
- Dizziness
- Insomnia
- Fatigue
Key clinical trials
- fNIRS in the Evaluation of Cognitive-motor Interference in Post-stroke Patients (NA)
- Running Environments on Physiological Responses, Emotion, Motivation, and Attention (NA)
- Living With Multimorbidity: Care Coordination and Symptom Management Program (COORDINATE) (NA)
- Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study (NA)
- Personalised Active Self-management of Sleep Apnea Program (NA)
- CFT Guided Self-help Intervention: Parents of Autistic Children (NA)
- Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT (NA)
- High-Intensity Interval Training Across Exercise Environments: Acute Effects on Physiological Stress, Cardiovascular Responses, Executive Function, and Psychological Experience (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Track A CI brief — competitive landscape report
- Track A updates RSS · CI watch RSS
- ATS Clinical Research portfolio CI